Showing results (21-30 of 209) with videos related to
Sort By:
Pageof 21
BMC Infectious Diseases|April 17, 2013
Inactivation of an enterovirus by airborne disinfectantsThomas Thevenin, Pierre-Emmanuel Lobert, Didier HoberMicroorganisms|June 15, 2023
Markers of Epstein-Barr Virus Infection in Patients with Multiple SclerosisCyril Debuysschere, Magloire Pandoua Nekoua, Didier HoberIntervirology|June 19, 2013
Inactivation of coxsackievirus B4, feline calicivirus and herpes simplex virus type 1: unexpected virucidal effect of a disinfectant on a non-enveloped virus applied onto a surfaceThomas Thevenin, Pierre Emmanuel Lobert, Didier HoberEmerging Infectious Diseases|February 9, 2008
Confronting potential influenza A (H5N1) pandemic with better vaccinesAzizul Haque, Didier Hober, Lloyd H KasperJournal of Medical Virology|April 25, 2014
Erythrovirus B19 and autoimmune thyroid diseases. Review of the literature and pathophysiological hypothesesCyril Page, Gilles Duverlie, Henri Sevestre, et al.Nature Reviews. Endocrinology|June 1, 2022
Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitusMagloire Pandoua Nekoua, Enagnon Kazali Alidjinou, Didier HoberMetabolism Open|August 20, 2020
Effects of a diet plus exercise program on thyroid function in patients with obesityYoussef Kouidrat, Momar Diouf, Rachel Desailloud, et al.Journal of Medical Virology|February 26, 2008
Coxsackievirus B4 infection of murine foetal thymus organ culturesFabienne Brilot, Hela Jaïdane, Vincent Geenen, et al.Discovery Medicine|September 1, 2011
Specificity of the coxsackievirus B4 VP4 capsid protein investigated in silicoAnne Goffard, Famara Sané, Magali Soumillon, et al.Journal of Molecular Biology|October 15, 2013
Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cellsEnagnon Kazali Alidjinou, Famara Sané, Ilka Engelmann, et al.Pageof 21